Runqing Lu

Affiliations: 
University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Immunology, Cell Biology, Oncology
Google:
"Runqing Lu"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lu RQ, Wu LX, Zhang J, et al. (2021) Prognostic value of transcript levels in adult Philadelphia-negative B-cell acute lymphoblastic leukemia. Hematology (Amsterdam, Netherlands). 26: 9-15
Zhang J, Lu WY, Zhang JM, et al. (2019) S100A16 suppresses the growth and survival of leukaemia cells and correlates with relapse and relapse free survival in adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia. British Journal of Haematology
Shukla V, Shukla A, Joshi SS, et al. (2016) Interferon regulatory factor 4 attenuates notch signaling to suppress the development of chronic lymphocytic leukemia. Oncotarget
Haney SL, Upchurch GM, Opavska J, et al. (2016) Promoter Hypomethylation and Expression Is Conserved in Mouse Chronic Lymphocytic Leukemia Induced by Decreased or Inactivated Dnmt3a. Cell Reports
Shukla A, Rai K, Shukla V, et al. (2016) Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL. Blood
Shukla V, Lu R. (2014) IRF4 and IRF8: Governing the virtues of B Lymphocytes. Frontiers in Biology. 9: 269-282
Mittal AK, Chaturvedi NK, Rai KJ, et al. (2014) Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease. Molecular Medicine (Cambridge, Mass.). 20: 290-301
Shukla V, Ma S, Joshi S, et al. (2014) Notch2 Is Critical for CLL Development in the IRF4-/-Vh11 Mice Blood. 124: 891-891
Shukla A, Rai K, Bociek G, et al. (2014) Role of Sprouty2 in the Pathogenesis of Chronic Lymphocytic Leukemia Blood. 124: 719-719
Pathak S, Ma S, Shukla V, et al. (2013) A role for IRF8 in B cell anergy. Journal of Immunology (Baltimore, Md. : 1950). 191: 6222-30
See more...